Use of potentially inappropriate medications in the care of frail older people

Aging Health

Volumn 6, Issue 6, 2010, Pages 705-716

  Gnjidic, Danijela ^a,b   Hilmer, Sarah N ^a,b  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

frail older people; frailty tools; inappropriate drug use; outcomes

Indexed keywords

ADVERSE OUTCOME; ARTICLE; CLINICAL ASSESSMENT TOOL; DRUG SAFETY; DRUG USE; ELDERLY CARE; FALL RISK ASSESSMENT; FRAIL ELDERLY; HEALTH STATUS; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; LIFE EXPECTANCY; MEDICATION ERROR; MORTALITY; OUTCOME ASSESSMENT; PATIENT SAFETY; PHYSICAL DISABILITY; PREDICTION; PRESCRIPTION; PUBLIC HEALTH PROBLEM; RISK ASSESSMENT; RISK BENEFIT ANALYSIS;

EID: 78650272956     PISSN: 1745509X     EISSN: 17455103     Source Type: Journal    
DOI: 10.2217/ahe.10.78     Document Type: Article

References (117)

1. Hilmer SN, McLachlan AJ, Le Couteur DG: Clinical pharmacology in the geriatric patient. Fundam. Clin. Pharmacol. 21, 217-230 (2007).
2. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW: Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 294, 716-724 (2005).
3. Bugeja G, Kumar A, Banerjee AK: Exclusion of elderly people from clinical research: a descriptive study of published reports. BMJ 315, 1059 (1997).
4. Schellevis FG, van der Velden J, van de Lisdonk E, van Eijk JT, van Weel C: Comorbidity of chronic diseases in general practice. J. Clin. Epidemiol. 46, 469-473 (1993). (Pubitemid 23194269)
5. Gurwitz JH, Col NF, Avorn J: The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA 268, 1417-1422 (1992).
6. Holmes HM: Rational prescribing for patients with a reduced life expectancy. Clin. Pharmacol. Ther. 85, 103-107 (2009).
7. Crystal S, Gaboda D, Lucas J, Gerhard T, Chakravarty S: Assessing medication exposures and outcomes in the frail elderly: assessing research challenges in nursing home pharmacotherapy. Med. Care 48, S23-S31 (2010).
8. McLean AJ, Le Couteur DG: Aging biology and geriatric clinical pharmacology. Pharmacol. Rev. 56, 163-184 (2004).
9. McLachlan AJ, Hilmer SN, Le Couteur DG: Variability in response to medicines in older people: phenotypic and genotypic factors. Clin. Pharmacol. Ther. 85, 431-433 (2009).
10. Nelson EA, Dannefer D: Aged heterogeneity: fact or fiction? The fate of diversity in gerontological research. Gerontologist 32, 17-23 (1992).
11. Spinewine A, Schmader KE, Barber N, et al.: Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 370, 173-184 (2007).
12. Barry PJ, Gallagher P, Ryan C: Inappropriate prescribing in geriatric patients. Curr. Psychiatry Rep. 10, 37-43 (2008).
13. OMahony D, Gallagher PF: Inappropriate prescribing in the older population: need for new criteria. Age Ageing 37, 138-141 (2008).
14. Laroche ML, Charmes JP, Bouthier F, Merle L: Inappropriate medications in the elderly. Clin. Pharmacol. Ther. 85, 94-97 (2009).
15. Page RL 2nd, Linnebur SA, Bryant LL, Ruscin JM: Inappropriate prescribing in the hospitalized elderly patient: defining the problem, evaluation tools, and possible solutions. Clin. Interv. Aging 5, 75-87 (2010).
16. Bergman H, Ferrucci L, Guralnik J, et al.: Frailty: an emerging research and clinical paradigm - issues and controversies. J. Gerontol. A Biol. Sci. Med. Sci. 62, 731-737 (2007).
17. van Kan GA, Rolland Y, Houles M, Gillette-Guyonnet S, Soto M, Vellas B: The assessment of frailty in older adults. Clin. Geriatr. Med. 26, 275-286 (2010).
18. Gill TM, Gahbauer EA, Han L, Allore HG: Trajectories of disability in the last year of life. N. Engl. J. Med. 362, 1173-1180 (2010).
19. Hilmer SN, Perera V, Mitchell S, et al.: The assessment of frailty in older people in acute care. Australas. J. Ageing 28, 182-188 (2009).
20. Ensrud KE, Ewing SK, Taylor BC, et al.: Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women. Arch. Intern. Med. 168, 382-389 (2008).
21. Ravaglia G, Forti P, Lucicesare A, Pisacane N, Rietti E, Patterson C: Development of an easy prognostic score for frailty outcomes in the aged. Age Ageing 37, 161-166 (2008).
22. Gobbens RJ, van Assen MA, Luijkx KG, Wijnen-Sponselee MT, Schols JM: The Tilburg Frailty Indicator: psychometric properties. J. Am. Med. Dir. Assoc. 11, 344-355 (2010).
23. Rockwood K, Song X, MacKnight C, et al.: A global clinical measure of fitness and frailty in elderly people. CMAJ 173, 489-495 (2005).
24. Fried LP, Tangen CM, Walston J, et al.: Frailty in older adults: evidence for a phenotype. J. Gerontol. A Biol. Sci. Med. Sci. 56, M146-M156 (2001).
25. Bandeen-Roche K, Xue QL, Ferrucci L, et al.: Phenotype of frailty: characterization in the womens health and aging studies. J. Gerontol. A Biol. Sci. Med. Sci. 61, 262-266 (2006).
26. Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G: Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J. Gerontol. A Biol. Sci. Med. Sci. 59, 255-263 (2004).
27. Leng S, Chaves P, Koenig K, Walston J: Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study. J. Am. Geriatr. Soc. 50, 1268-1271 (2002).
28. Montero-Odasso M, Duque G: Vitamin D in the aging musculoskeletal system: an authentic strength preserving hormone. Mol. Aspects Med. 26, 203-219 (2005).
29. Bartali B, Frongillo EA, Bandinelli S, et al.: Low nutrient intake is an essential component of frailty in older persons. J. Gerontol. A Biol. Sci. Med. Sci. 61, 589-593 (2006).
30. Morley JE, Kim MJ, Haren MT: Frailty and hormones. Rev. Endocr. Metab. Disord. 6, 101-108 (2005).
31. Hilmer SN, Ford G: General principles of pharmacology. In: Hazzards Geriatric Medicine & Gerontology (6th Edition). Halter JB, Ouslander JG, Tinetti M, et al. (Eds). McGraw-Hill, NY, USA, 99-117 (2009).
32. Bales CW, Ritchie CS: Sarcopenia, weight loss, and nutritional frailty in the elderly. Annu. Rev. Nutr. 22, 309-323 (2002).
33. Walston J, McBurnie MA, Newman A, et al.: Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch. Intern. Med. 162, 2333-2341 (2002).
34. Schwartz JB: Erythromycin breath test results in elderly, very elderly, and frail elderly persons. Clin. Pharmacol. Ther. 79, 440-448 (2006).
35. Wynne H: Drug metabolism and ageing. J. Br. Menopause Soc. 11, 51-56 (2005).
36. Shlipak MG, Stehman-Breen C, Fried LF, et al.: The presence of frailty in elderly persons with chronic renal insufficiency. Am. J. Kidney Dis. 43, 861-867 (2004).
37. Wasen E, Isoaho R, Vahlberg T, Kivela SL, Irjala K: Association between markers of renal function and C-reactive protein level in the elderly: confounding by functional status. Scand. J. Clin. Lab. Invest. 68, 484-491 (2008).
38. Singh D, Whooley MA, Ix JH, Ali S, Shlipak MG: Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study. Nephrol. Dial. Transplant. 22, 1087-1092 (2007). (Pubitemid 46523422)
39. Wynne HA, Yelland C, Cope LH, Boddy A, Woodhouse KW, Bateman DN: The association of age and frailty with the pharmacokinetics and pharmacodynamics of metoclopramide. Age Ageing 22, 354-359 (1993).
40. Mitchell S, Hilmer SN, Murnion BP, Matthews S: Hepatotoxicity of therapeutic short-course paracetamol in hospital inpatients: impact of ageing and frailty. J. Clin. Pharm. Therapeut. (2010) (In Press).
41. World Health Organization. WHO Medicines Strategy Report 2008-2013. WHO, USA (2008).
42. Lindley CM, Tully MP, Paramsothy V, Tallis RC: Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 21, 294-300 (1992).
43. Carey IM, De Wilde S, Harris T, et al.: What factors predict potentially inappropriate primary care prescribing in older people? Analysis of UK primary care patient record database. Drugs Aging 25, 693-706 (2008).
44. Johnell K, Weitoft GR, Fastbom J: Sex differences in inappropriate drug use: a register-based study of over 600,000 older people. Ann. Pharmacother. 43, 1233-1238 (2009).
45. Lechevallier-Michel N, Gautier-Bertrand M, Alperovitch A, et al.: Frequency and risk factors of potentially inappropriate medication use in a community-dwelling elderly population: results from the 3C Study. Eur. J. Clin. Pharmacol. 60, 813-819 (2005).
46. Perera V, Bajorek BV, Matthews S, Hilmer SN: The impact of frailty on the utilisation of antithrombotic therapy in older patients with atrial fibrillation. Age Ageing 38, 156-162 (2009).
47. Field TS, Gurwitz JH, Avorn J, et al.: Risk factors for adverse drug events among nursing home residents. Arch. Intern. Med. 161, 1629-1634 (2001).
48. Gurwitz JH, Field TS, Judge J, et al.: The incidence of adverse drug events in two large academic long-term care facilities. Am. J. Med. 118, 251-258 (2005).
49. Gurwitz JH, Field TS, Avorn J, et al.: Incidence and preventability of adverse drug events in nursing homes. Am. J. Med. 109, 87-94 (2000).
50. Rancourt C, Moisan J, Baillargeon L, Verreault R, Laurin D, Gregoire JP: Potentially inappropriate prescriptions for older patients in long-term care. BMC Geriatrics 4, 9 (2004).
51. Bergman A, Olsson J, Carlsten A, Waern M, Fastbom J: Evaluation of the quality of drug therapy among elderly patients in nursing homes. Scand. J. Prim. Health Care 25, 9-14 (2007).
52. Brook RH: Quality-can we measure it. N. Engl. J. Med. 296, 170-172 (1977).
53. Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC: Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch. Intern. Med. 151, 1825-1832 (1991).
54. Beers MH: Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch. Intern. Med. 157, 1531-1536 (1997).
55. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH: Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch. Intern. Med. 163, 2716-2724 (2003).
56. McLeod PJ, Huang AR, Tamblyn RM, Gayton DC: Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ 156, 385-391 (1997).
57. Naugler CT, Brymer C, Stolee P, Arcese ZA: Development and validation of an improving prescribing in the elderly tool. Can. J. Clin. Pharmacol. 7, 103-107 (2000).
58. Laroche ML, Charmes JP, Merle L: Potentially inappropriate medications in the elderly: a French consensus panel list. Eur. J. Clin. Pharmacol. 63, 725-731 (2007).
59. Imai H, Beers MH, Fick DM, et al.: Development of Japanese Beers Criteria for inappropriate medication use in elderly patients. [In Japanese]. Japan. Med. Assoc. J. 137, 84-91 (2008).
60. Gallagher P, Ryan C, Byrne S, Kennedy J, OMahony D: STOPP (Screening Tool of Older Persons Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int. J. Clin. Pharmacol. Ther. 46, 72-83 (2008).
61. Hanlon JT, Schmader KE, Samsa GP, et al.: A method for assessing drug therapy appropriateness. J. Clin. Epidemiol. 45, 1045-1051 (1992).
62. Jeffrey S, Ruby C, Tverlisky J, Hanlon JT: Effect of an interdisciplinary team on suboptimal prescribing in a long-term care facility. Consult Pharm. 14, 1386-1391 (1999).
63. Higashi T, Shekelle PG, Solomon DH, et al.: The quality of pharmacologic care for vulnerable older patients. Ann. Intern. Med. 140, 714-720 (2004).
64. Stefanacci RG, Cavallaro E, Beers MH, Fick DM: Developing explicit positive beers criteria for preferred central nervous system medications in older adults. Consult. Pharm. 24, 601-610 (2009).
65. Lane CJ, Bronskill SE, Sykora K, et al.: Potentially inappropriate prescribing in Ontario community-dwelling older adults and nursing home residents. J. Am. Geriatr. Soc. 52, 861-866 (2004).
66. Stuck AE, Beers MH, Steiner A, Aronow HU, Rubenstein LZ, Beck JC: Inappropriate medication use in community-residing older persons. Arch. Intern. Med. 154, 2195-2200 (1994).
67. Beers MH, Ouslander JG, Fingold SF, et al.: Inappropriate medication prescribing in skilled-nursing facilities. Ann. Intern. Med. 117, 684-689 (1992).
68. Gallagher PF, Barry PJ, Ryan C, Hartigan I, OMahony D: Inappropriate prescribing in an acutely ill population of elderly patients as determined by Beers criteria. Age Ageing 37, 96-101 (2008).
69. Rothberg MB, Pekow PS, Liu F, et al.: Potentially inappropriate medication use in hospitalized elders. J. Hosp. Med. 3, 91-102 (2008).
70. Laroche ML, Charmes JP, Nouaille Y, Fourrier A, Merle L: Impact of hospitalisation in an acute medical geriatric unit on potentially inappropriate medication use. Drugs Aging 23, 49-59 (2006).
71. Rognstad S, Brekke M, Fetveit A, Spigset O, Wyller TB, Straand J: The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. A modified Delphi study. Scand. J. Prim. Health Care 27, 153-159 (2009).
72. Fusco D, Lattanzio F, Tosato M, et al.: Development of Criteria to Assess Appropriate Medication Use Among Elderly Complex Patients (CRIME) project: rationale and methodology. Drugs Aging. 26(Suppl. 1), 3-13 (2009).
73. Winit-Watjana W, Sakulrat P, Kespichayawattana J: Criteria for high-risk medication use in Thai older patients. Arch. Gerontol. Geriatr. 47, 35-51 (2008).
74. Barry PJ, OKeefe N, OConnor KA, OMahony D: Inappropriate prescribing in the elderly: a comparison of the Beers criteria and the Improved Prescribing in the Elderly Tool (IPET) in acutely ill elderly hospitalized patients. J. Clin. Pharm. Ther. 31, 617-626 (2006).
75. Ryan C, OMahony D, Kennedy J, Weedle P, Byrne S: Potentially inappropriate prescribing in an Irish elderly population in primary care. Br. J. Clin. Pharmacol. 68, 936-947 (2009).
76. Barry PJ, Gallagher P, Ryan C, OMahony D: START (screening tool to alert doctors to the right treatment) - an evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing 36, 632-638 (2007).
77. Pyszka LL, Seys Ranola TM, Milhans SM: Identification of inappropriate prescribing in geriatrics at a veterans affairs hospital using STOPP/START screening tools. Consult. Pharm. 25, 365-373 (2010).
78. Ryan C, OMahony D, Byrne S: Application of STOPP and START criteria: interrater reliability among pharmacists. Ann. Pharmacother. 43, 1239-1244 (2009).
79. Samsa GP, Hanlon JT, Schmader KE, et al.: A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validity. J. Clin. Epidemiol. 47, 891-896 (1994).
80. Fitzgerald LS, Hanlon JT, Shelton PS, et al.: Reliability of a modified medication appropriateness index in ambulatory older persons. Ann. Pharmacother. 31, 543-548 (1997).
81. Hajjar ER, Hanlon JT, Sloane RJ, et al.: Unnecessary drug use in frail older people at hospital discharge. J. Am. Geriatr. Soc. 53, 1518-1523 (2005).
82. Lund BC, Carnahan RM, Egge JA, Chrischilles EA, Kaboli PJ: Inappropriate prescribing predicts adverse drug events in older adults. Ann. Pharmacother. 44, 957-963 (2010).
83. Wenger NS, Shekelle PG: Assessing care of vulnerable elders: ACOVE project overview. Ann. Intern. Med. 135, 642-646 (2001).
84. Wenger NS, Solomon DH, Roth CP, et al.: The quality of medical care provided to vulnerable community-dwelling older patients. Ann. Intern. Med. 139, 740-747 (2003).
85. Steinman MA, Landefeld CS, Rosenthal GE, Berthenthal D, Sen S, Kaboli PJ: Polypharmacy and prescribing quality in older people. J. Am. Geriatr. Soc. 54, 1516-1523 (2006).
86. Chang CM, Liu PY, Yang YH, Yang YC, Wu CF, Lu FH: Use of the Beers criteria to predict adverse drug reactions among first-visit elderly outpatients. Pharmacotherapy 25, 831-838 (2005).
87. Chrischilles EA, VanGilder R, Wright K, Kelly M, Wallace RB: Inappropriate medication use as a risk factor for self-reported adverse drug effects in older adults. J. Am. Geriatr. Soc. 57, 1000-1006 (2009).
88. Zuckerman IH, Langenberg P, Baumgarten M, et al.: Inappropriate drug use and risk of transition to nursing homes among community-dwelling older adults. Med. Care 44, 722-730 (2006).
89. Berdot S, Bertrand M, Dartigues JF, et al.: Inappropriate medication use and risk of falls - a prospective study in a large community-dwelling elderly cohort. BMC Geriatr. 9, 30 (2009).
90. Fu AZ, Liu GG, Christensen DB: Inappropriate medication use and health outcomes in the elderly. J. Am. Geriatr. Soc. 52, 1934-1939 (2004).
91. Hanlon JT, Fillenbaum GG, Kuchibhatla M, et al.: Impact of inappropriate drug use on mortality and functional status in representative community dwelling elders. Med. Care 40, 166-176 (2002).
92. Espino DV, Bazaldua OV, Palmer RF, et al.: Suboptimal medication use and mortality in an older adult community-based cohort: results from the Hispanic EPESE Study. J. Gerontol. A Biol. Sci. Med. Sci. 61, 170-175 (2006).
93. Schmader KE, Hanlon JT, Landsman PB, Samsa GP, Lewis IK, Weinberger M: Inappropriate prescribing and health outcomes in elderly veteran outpatients. Ann. Pharmacother. 31, 529-533 (1997).
94. Perri III M, Menon AM, Deshpande AD, et al.: Adverse outcomes associated with inappropriate drug use in nursing homes. Ann. Pharmacother. 39, 405-411 (2005).
95. Lau DT, Kasper JD, Potter DE, Lyles A, Bennett RG: Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents. Arch. Intern. Med. 165, 68-74 (2005).
96. Gupta S, Rappaport HM, Bennett LT: Inappropriate drug prescribing and related outcomes for elderly medicaid beneficiaries residing in nursing homes. Clin. Ther. 18, 183-196 (1996).
97. Raivio MM, Laurila JV, Strandberg TE, Tilvis RS, Pitkala KH: Use of inappropriate medications and their prognostic significance among in-hospital and nursing home patients with and without dementia in Finland. Drugs Aging 23, 333-343 (2006).
98. Passarelli MC, Jacob-Filho W, Figueras A: Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause. Drugs Aging 22, 767-777 (2005).
99. Akazawa M, Imai H, Igarashi A, Tsutani K: Potentially inappropriate medication use in elderly Japanese patients. Am. J. Geriatr. Pharmacother. 8, 146-160 (2010).
100. Laroche ML, Charmes JP, Nouaille Y, Picard N, Merle L: Is inappropriate medication use a major cause of adverse drug reactions in the elderly? Br. J. Clin. Pharmacol. 63, 177-186 (2007).
101. Onder G, Landi F, Cesari M, Gambassi G, Carbonin P, Bernabei R: Inappropriate medication use among hospitalized older adults in Italy: results from the Italian Group of Pharmacoepidemiology in the Elderly. Eur. J. Clin. Pharmacol. 59, 157-162 (2003).
102. Gallagher P, OMahony D: STOPP (Screening Tool of Older Persons Potentially Inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers criteria. Age Ageing 37, 673-679 (2008).
103. Handler SM, Wright RM, Ruby CM, Hanlon JT: Epidemiology of medication-related adverse events in nursing homes. Am. J. Geriatr. Pharmacother. 4, 264-272 (2006).
104. Hilmer SN, Mager DE, Simonsick EM, et al.: A drug burden index to define the functional burden of medications in older people. Arch. Intern. Med. 167, 781-787 (2007).
105. Hilmer SN, Mager DE, Simonsick EM, et al.: Drug burden index score and functional decline in older people. Am. J. Med. 122, 1142-1149, e1-e2 (2009).
106. Gnjidic D, Cumming RG, Le Couteur DG, et al.: Drug Burden Index and physical function in older Australian men. Br. J. Clin. Pharmacol. 68, 97-105 (2009).
107. Wilson NM, Hilmer SN, March LM, et al.: Associations between drug burden index and physical function in older people in residential aged care facilities. Age Ageing 39, 503-507 (2010).
108. Fillenbaum GG, Hanlon JT, Landerman LR, et al.: Impact of inappropriate drug use on health services utilization among representative older community-dwelling residents. Am. J. Geriatr. Pharmacother. 2, 92-101 (2004).
109. Aparasu RR, Mort JR: Prevalence, correlates, and associated outcomes of potentially inappropriate psychotropic use in the community-dwelling elderly. Am. J. Geriatr. Pharmacother. 2, 102-111 (2004).
110. Rask KJ, Wells KJ, Teitel GS, Hawley JN, Richards C, Gazmararian JA: Can an algorithm for appropriate prescribing predict adverse drug events? Am. J. Manag. Care 11, 145-151 (2005).
111. Klarin I, Wimo A, Fastbom J: The association of inappropriate drug use with hospitalisation and mortality: a population-based study of the very old. Drugs Aging 22, 69-82 (2005).
112. Fick DM, Mion LC, Beers MH: Health outcomes associated with potentially inappropriate medication use in older adults. Res. Nurs. Health 31, 42-51 (2008).
113. Franic DM, Jiang JZ: Potentially inappropriate drug use and health-related quality of life in the elderly. Pharmacotherapy 26, 768-778 (2006).
114. Chin MH, Wang LC, Jin L, et al.: Appropriateness of medication selection for older persons in an urban academic emergency department. Acad. Emerg. Med. 6, 1232-1242 (1999).
115. Corsonello A, Pedone C, Lattanzio F, et al.: Potentially inappropriate medications and functional decline in elderly hospitalized patients. J. Am. Geriatr. Soc. 57, 1007-1014 (2009).
116. Onder G, Landi F, Liperoti R, Fialova D, Gambassi G, Bernabei R: Impact of inappropriate drug use among hospitalized older adults. Eur. J. Clin. Pharmacol. 61, 453-459 (2005).
117. Page RL 2nd, Ruscin JM: The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use. Am. J. Geriatr. Pharmacother. 4, 297-305 (2006).